Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
115.86 USD | +0.53% | -1.68% | +6.27% |
12/09 | Merck Says Health Canada Approved Keytruda as Treatment for Hard-to-Treat Solid Tumors | MT |
11/09 | Merck: positive results for HPV vaccine | CF |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
1m. EPS revision | 1m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | ||
---|---|---|---|---|---|
Average | |||||
Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- MRK Stock
- Consensus Merck & Co., Inc.
- Estimates Revisions
MarketScreener is also available in this country: United States.
Switch edition